The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Survivin Essential for the Maturation of Antigen Presenting Cells in Rheumatoid Arthritis Patients

Survivin Essential for the Maturation of Antigen Presenting Cells in Rheumatoid Arthritis Patients

January 2, 2013 • By Lara C. Pullen, PhD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Patients with rheumatoid arthritis (RA) have high levels of survivin and Flt3 ligand (Flt3L) in their blood and synovial fluid. Survivin has been shown to be an early and independent biomarker for patients with severe, joint-destructive RA as well as for patients with therapy-resistant RA. New research by investigators in this subject area suggests that, in patients with RA, survivin is essential for the survival of leukocytes as they differentiate and mature into dendritic cells, thereby raising it as a potential therapeutic target.

You Might Also Like
  • New Research Focuses on Bone Erosion and Repair in Rheumatoid Arthritis
  • TNF-α Impairs Regulatory T Cells in Patients with Rheumatoid Arthritis
  • Clues Emerge to Bone Health, Destruction in Rheumatoid Arthritis
Also By This Author
  • Researchers Hone in on Defect in Autophagy that May Underlie Lupus

Previous studies have shown that Flt3/Flt3L signaling is important for hematopoietic maturation. Studies also have demonstrated that peripheral dendritic cells mature in the spleen and do so in a process that is dependent on Flt3 expression. When Flt3L-induced expression was evaluated for its effect on different survivin transcripts, it was found that the short survivin40 transcript is modulated by Flt3 in the bone marrow.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Sofia E. M. Andersson and colleagues worked in the laboratory of Maria I. Bokarewa, MD, PhD, in the University of Goteberg in Sweden and evaluated the requirement of Flt3/Flt3L signaling for expression of survivin.1 They measured survivin levels in the blood of 104 healthy controls and calculated that a level of survivin greater than 450 pg/ml was present in fewer than 5% of healthy individuals. The investigators then sought to better understand the relationship between survivin and Flt3L levels in RA patients. They used arthritic mice and found that survivin gene expression was four times higher in the bone marrow than in the spleen. Moreover, when mice were treated with Flt3L, transcription of survivin was higher in the bone marrow than in the spleen.

The team then hypothesized that blocking the Flt3 receptor would affect survivin production in the bone marrow. The Flt3 inhibitor sunitinib reduced survivin expression in the MHCII+CD11-chi dendritic cell population in the spleen. They also found that Flt3/Flt3L system was downregulated when BALB/c mice were treated with survivin shRNA.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Thus, in the current study, the authors were able to treat mice with an Flt3 inhibitor and thereby decrease survivin expression in the bone marrow and in the dendritic cell population in the spleen. When survivin transcription was inhibited by shRNA lentiviral constructs, there was a corresponding reduction in the gene expression of Flt3L. The authors concluded that survivin expression is a downstream event of Flt3L signaling and that it serves as an essential mechanism of survival for bone marrow and spleen hematopoietic cells as they mature and differentiate into antigen presenting cells.

Pages: 1 2 | Single Page

Filed Under: Conditions, Research Reviews, Rheumatoid Arthritis Tagged With: RA, Rheumatoid arthritis, survivin

You Might Also Like:
  • New Research Focuses on Bone Erosion and Repair in Rheumatoid Arthritis
  • TNF-α Impairs Regulatory T Cells in Patients with Rheumatoid Arthritis
  • Clues Emerge to Bone Health, Destruction in Rheumatoid Arthritis
  • Plasma Cells, Synovial Compartment Implicated in Tenacity of Rheumatoid Arthritis

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.